Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
WAYRILZ - official renal restriction
Product / population
WAYRILZ - official renal restriction; selected renal passages, not a complete prescribing monograph.
Renal method
Creatinine clearance (CrCl), mL/min; equation not specified in the selected passage. Section 8.7 uses categorical severity; no additional numeric boundary is inferred.
Source revision
Prescribing information revised August 2025.
Retrieved
2026-09-09
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
WAYRILZ: limited RX PK wording versus official severe-renal avoidance
The RX study boundary and the official categorical renal instruction are different types of evidence. A PK-only extraction can obscure a clinically important restriction.
What to reconcile: Read official section 8.7 before use. Do not convert the lowest studied CrCl into a newly invented avoidance cutoff.
DailyMed / Genzyme Corporation · WAYRILZ - official renal restriction; selected renal passages, not a complete prescribing monograph.
Renal method: Creatinine clearance (CrCl), mL/min; equation not specified in the selected passage. Section 8.7 uses categorical severity; no additional numeric boundary is inferred. Source date: Prescribing information revised August 2025. Retrieved: 2026-09-09
Restriction or avoidance guidance. Read the specific threshold, age, formulation and dialysis exclusions; do not generalize across products.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
Section 8.7 advises avoiding WAYRILZ in severe renal impairment and requires no modification for mild or moderate impairment. The separate PK section covers CrCl 46-89 mL/min and states that values below 46 were not studied. Do not equate the lowest studied CrCl with the categorical severe-impairment restriction or invent a numerical threshold to bridge the two passages. No dialysis regimen is supplied here. This restriction supplements, rather than repairs, the limited RX rendering.
RDM52-official-rilzabrutinib-wayrilz-384a1a0c39-C1 · Source locator: Sections 8.7 and 12.3: renal impairment; label title and revision.
Creatinine clearance (CrCl), mL/min; equation not specified in the selected passage. Section 8.7 uses categorical severity; no additional numeric boundary is inferred.
Source date/version
Prescribing information revised August 2025.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.